Movement Alert｜Twist Bioscience Corp Rises 12.21% in Regular Trading, Biotech Sector Surge Combined with Strong Q4 Guidance Fuels Oversold Rebound

Market Focus08-19 21:37

On August 19, Twist Bioscience Corp rose 12.21% in regular trading, trading at $135.01/share, with turnover of $47.75 million. The stock had closed down 6.68% the prior session at $116.10 before staging a sharp recovery.

The rally was driven by a broad biotech sector surge, with peer Moderna soaring approximately 88.5%, BioNTech climbing 16.36%, and Gilead Sciences gaining 2.36%, significantly lifting industry sentiment. On the fundamental side, the company reported fiscal Q3 revenue of $118.376 million on August 3, beating the consensus estimate of $114.49 million. More importantly, its Q4 revenue guidance of $123 million to $124 million substantially exceeded the FactSet estimate of $117.4 million. As a core DNA synthesis supplier within the AI-driven drug discovery value chain, the company has demonstrated accelerating protein business growth and recently completed a $300 million equity offering to expand production capacity, reinforcing improving fundamentals that supported the technical rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180633158?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-19 21:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180633158","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Rises 12.21% in Regular Trading, Biotech Sector Surge Combined with Strong Q4 Guidance Fuels Oversold Rebound","media":"Market Focus","content":"<p><p>On August 19, Twist Bioscience Corp rose 12.21% in regular trading, trading at $135.01/share, with turnover of $47.75 million. The stock had closed down 6.68% the prior session at $116.10 before staging a sharp recovery.</p><p>The rally was driven by a broad biotech sector surge, with peer Moderna soaring approximately 88.5%, BioNTech climbing 16.36%, and Gilead Sciences gaining 2.36%, significantly lifting industry sentiment. On the fundamental side, the company reported fiscal Q3 revenue of $118.376 million on August 3, beating the consensus estimate of $114.49 million. More importantly, its Q4 revenue guidance of $123 million to $124 million substantially exceeded the FactSet estimate of $117.4 million. As a core DNA synthesis supplier within the AI-driven drug discovery value chain, the company has demonstrated accelerating protein business growth and recently completed a $300 million equity offering to expand production capacity, reinforcing improving fundamentals that supported the technical rebound.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Rises 12.21% in Regular Trading, Biotech Sector Surge Combined with Strong Q4 Guidance Fuels Oversold Rebound</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Rises 12.21% in Regular Trading, Biotech Sector Surge Combined with Strong Q4 Guidance Fuels Oversold Rebound\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-19 21:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 19, Twist Bioscience Corp rose 12.21% in regular trading, trading at $135.01/share, with turnover of $47.75 million. The stock had closed down 6.68% the prior session at $116.10 before staging a sharp recovery.</p><p>The rally was driven by a broad biotech sector surge, with peer Moderna soaring approximately 88.5%, BioNTech climbing 16.36%, and Gilead Sciences gaining 2.36%, significantly lifting industry sentiment. On the fundamental side, the company reported fiscal Q3 revenue of $118.376 million on August 3, beating the consensus estimate of $114.49 million. More importantly, its Q4 revenue guidance of $123 million to $124 million substantially exceeded the FactSet estimate of $117.4 million. As a core DNA synthesis supplier within the AI-driven drug discovery value chain, the company has demonstrated accelerating protein business growth and recently completed a $300 million equity offering to expand production capacity, reinforcing improving fundamentals that supported the technical rebound.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1180633158","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180633158","pubTimestamp":1787146647,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 19, Twist Bioscience Corp rose 12.21% in regular trading, trading at $135.01/share, with turnover of $47.75 million. The stock had closed down 6.68% the prior session at $116.10 before...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势警报|Twist Bioscience Corp 常规交易中上涨 12.21%，生物技术板块飙升加上第四季度强劲指引推动超卖反弹","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On August 19, Twist Bioscience Corp rose 12.21% in regular trading, trading at $135.01/share, with turnover of $47.75 million. The stock had closed down 6.68% the prior session at $116.10 before staging a sharp recovery.The rally was driven by a broad biotech sector surge, with peer Moderna soaring approximately 88.5%, BioNTech climbing 16.36%, and Gilead Sciences gaining 2.36%, significantly lifting industry sentiment. On the fundamental side, the company reported fiscal Q3 revenue of $118.376 million on August 3, beating the consensus estimate of $114.49 million. More importantly, its Q4 revenue guidance of $123 million to $124 million substantially exceeded the FactSet estimate of $117.4 million. As a core DNA synthesis supplier within the AI-driven drug discovery value chain, the company has demonstrated accelerating protein business growth and recently completed a $300 million equity offering to expand production capacity, reinforcing improving fundamentals that supported the technical rebound.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180633158","isCrawlerRequest":true}